Clinical trials offer the opportunity to test new therapeutic treatments and advance care, but trials often hit logistical barriers. Because trials have typically occurred in a physical research...

Kidney failure affects Black individuals at four times the rate of white individuals in the U.S.,[1] but fewer Black patients are put on kidney transplant waiting lists and even fewer receive...

At the annual Renal Physicians Association (RPA) meeting in Dallas, Texas, March 24-27, DaVita chief transformation officer Misha Palecek spoke candidly about the nephrology community’s...

Of the 37 million Americans who have kidney disease, an estimated 90% don’t know they have it. Often, it can go undetected because patients can present few or no symptoms until they approach or...

New technologies are helping to expand access and increase patient confidence to choose home dialysis more than ever before.